Overview

Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol

Status:
Enrolling by invitation

Trial end date:
2022-11-11

Target enrollment:

Participant gender:

Summary

Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Zenith Epigenetics